← ANALYSTS · TIPRANKS
Debanjana Chatterjee · JonesTrading
Hits
68%
119 of 176 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+45.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
11
Buy / hold / sell: 10 / 1 / 0
Upside of the analyst’s targets
+370.8%
Average over 11 current targets, to the last price
The market’s answer to the ratings
+5.1%
Day-0 move against SPY in the rating’s direction, average over 8 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 14on TipRanks 07:30 | CTNMIWMContineum Therapeutics, Inc. Class A · $297M | Reiterated | Buy | $24.00 → $30.00+25.0% | +323.7% | −2.2%next day −3.2% | ↗ |
| Oct 7on TipRanks 11:10 | EYPTIWMEyePoint Pharmaceuticals · $271M | Reiterated | Buy | $20.00 | +568.9% | +5.0%next day +4.6% · 5 days −8.4% | ↗ |
| Oct 5on TipRanks 16:25 | IRDIWMOpus Genetics · $337M | Assigned | Buy | $10.00 → $17.00+70.0% | +342.7% | −0.5%next day +0.9% · 5 days −3.1% | ↗ |
| Oct 1on TipRanks 08:10 | SYREIWMSpyre Therapeutics · $7.3B | Assigned | Buy | $121 → $130+7.4% | +62.7% | +0.8%next day +2.9% · 5 days −12.5% | ↗ |
| Sep 30on TipRanks 10:10 | CTNMIWMContineum Therapeutics, Inc. Class A · $297M | Assigned | Buy | $24.00 → $26.00+8.3% | +267.2% | +16.9%next day −3.4% · 5 days −7.1% | ↗ |
| Sep 27on TipRanks Sep 28 00:45 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | $31.00 | +286.5% | +8.3%next day −6.0% · 5 days −10.4% | ↗ |
| Sep 27on TipRanks 17:50 | EYPTIWMEyePoint Pharmaceuticals · $271M | Reiterated | Buy | $20.00 | +568.9% | −7.8%next day +3.5% · 5 days −6.0% | ↗ |
| Sep 27on TipRanks 17:30 | SYREIWMSpyre Therapeutics · $7.3B | Reiterated | Buy | $140 → $121−13.6% | +51.4% | +0.9%next day −1.1% · 5 days +6.9% | ↗ |
| Sep 27on TipRanks 10:30 | ARMPIWMArmata Pharmaceuticals · $115M | Reiterated | Buy | $20.00 | +493.5% | +1.8%next day −4.8% · 5 days −4.4% | ↗ |
| Sep 9on TipRanks 09:45 | IRDIWMOpus Genetics · $337M | Reiterated | Buy | $10.00 | +160.4% | +32.5%next day +6.5% · 5 days −4.5% | ↗ |
| Sep 9on TipRanks 06:50 | PHVSPharvaris · $2.1B | Reiterated | Buy | $52.00 → $65.00+25.0% | +134.3% | +0.2%next day 0.0% · 5 days +0.6% | ↗ |
| Aug 14on TipRanks 12:35 | NTLAIWMIntellia Therapeutics · $1.6B | Reiterated | Buy | $29.00 | +153.9% | +0.9%next day +2.0% · 5 days +9.2% | ↗ |
| Aug 13on TipRanks 15:35 | TRVIIWMTrevi Therapeutics · $1.7B | Assigned | Buy | $24.00 → $28.00+16.7% | +135.7% | +1.7%next day +1.9% · 5 days +2.5% | ↗ |
| Aug 12on TipRanks 16:25 | ABSIIWMAbSci · $1.5B | Reiterated | Buy | $13.00 | +57.6% | −1.1%next day −2.8% · 5 days +0.1% | ↗ |
| Aug 10on TipRanks 06:50 | SIONIWMSionna Therapeutics, Inc. · $184M | Downgrade | Hold | $63.00 | +1,519.5% | −91.2%next day +13.7% · 5 days +31.4% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗